RE:RE:RE:RE:RE:Board member's thoughts Allow me to showcase how bad Supreme is at making deals.
The only deal (in recent memory-correct me if im wrong) is the Medigrow Lethoso deal $10 for 10%... valuing the company at $100m.
Compare that to Aphria's and Canopys Lethoso deals.
Canopy buys 100% for Daddy Cann Lesotho $29m
Aphria JV for $4M Verve Dynamics Inc
Even THC Biomed started their own Lesotho subsidiary "It estimates that the process to obtain the facility and the license, not including rental and license fees, will cost approximately USD $85,000 and take several months."
Ill try to be constructive and compare the management approces of Supreme and Aphria (just because I follow them pretty well)
Lets compare construction and capacity.
Supreme has been building their same facility for well over 2 years now, and have used funds from the past 2 raises to finance it, they will even use portion of 100m raised to complete it, which is embarrassing. "The Company intends to use the net proceeds of the Offering for the construction and development of its existing and planned facilities in Canada."
Most other companies projects are close to completion and coming online early 2019, for example Aphria is
and Vic mentioned they will be pumping out 20,000kg a month by June
Supreme:
Current annual production run rate of
13,333 kg (Sept 1, 2018)
• Estimated production run rate of 50,000 kg
at full capacity (est. early 2019)
Now lets compare the forward thinking'ness of the two companies:
Aphria (From their investor deck)
CATEGORY MUST HAVES
Backed by our team of R&D experts and partners, we have a solid plan in place
to bring today’s top products to our patients & consumers (once permitted).
Softgel Capsules Pending Health Canada approval
Topical Oil In-House & Partnership TBA
Vapes, Concentrates, Edibles (chocolates, candies, mints, infused foods) In-House & Partnership TBA Beverages (RTD, teas etc…) Partnership TBA
Topicals (Creams, balms, compounds) In-House & Partnership TBA
Medical Delivery Systems (strips, transdermal patches)
If you listened to the past two interview of Fowler and even Nav now, all the mention is their perceived customer hard on for premium flower. 1 Brand, 4 strains, no sativa, nothing besides flower. And some mention of oils from Lethoso but who knows when that will be available.
Now look how behind they are operationally:
They are just now hiring for basic operational roles like - Graphic Designer, Director of Marketing, Social media manager,
https://www.supreme.ca/Careers/default.aspx
Where as Aphria is hiring forwarding thinking roles such as: Director of Innovation, Beverage formulation chemist, research and dev technician, director of extraction and refinement
https://ca.indeed.com/cmp/Aphria-Inc./jobs?clearPrefilter=1#cmp-menu-container
maritimedreamer wrote: meowmeow.... so tell me this what other management team is more experienced then in the cannabis market? Do you really think the CEOs of Aprhia, ACB, CGC for example know more about the market and cannabis then Nav or Fowler? If you took SP out of it.... these guys are probably further ahead then some of these companies with concern to their build out etc.... how many of these companies have these huge pipe dream greenhouses that are not even close to being completed? Also please tell me how you came to conclusion that they are over budget? what numbers did you use to derive that? i'm very interested.....also what exactly makes the management stubborn? I'm interested in understanding your perspective..... here to discuss not here to bash your comments as you still have valid concerns.....